1032 related articles for article (PubMed ID: 28838210)
1. De-escalating and escalating treatments for early-stage breast cancer: the St. Gallen International Expert Consensus Conference on the Primary Therapy of Early Breast Cancer 2017.
Curigliano G; Burstein HJ; Winer EP; Gnant M; Dubsky P; Loibl S; Colleoni M; Regan MM; Piccart-Gebhart M; Senn HJ; Thürlimann B; ; André F; Baselga J; Bergh J; Bonnefoi H; Brucker SY; Cardoso F; Carey L; Ciruelos E; Cuzick J; Denkert C; Di Leo A; Ejlertsen B; Francis P; Galimberti V; Garber J; Gulluoglu B; Goodwin P; Harbeck N; Hayes DF; Huang CS; Huober J; Hussein K; Jassem J; Jiang Z; Karlsson P; Morrow M; Orecchia R; Osborne KC; Pagani O; Partridge AH; Pritchard K; Ro J; Rutgers EJT; Sedlmayer F; Semiglazov V; Shao Z; Smith I; Toi M; Tutt A; Viale G; Watanabe T; Whelan TJ; Xu B
Ann Oncol; 2017 Aug; 28(8):1700-1712. PubMed ID: 28838210
[TBL] [Abstract][Full Text] [Related]
2. Tailoring therapies--improving the management of early breast cancer: St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2015.
Coates AS; Winer EP; Goldhirsch A; Gelber RD; Gnant M; Piccart-Gebhart M; Thürlimann B; Senn HJ;
Ann Oncol; 2015 Aug; 26(8):1533-46. PubMed ID: 25939896
[TBL] [Abstract][Full Text] [Related]
3. Understanding breast cancer complexity to improve patient outcomes: The St Gallen International Consensus Conference for the Primary Therapy of Individuals with Early Breast Cancer 2023.
Curigliano G; Burstein HJ; Gnant M; Loibl S; Cameron D; Regan MM; Denkert C; Poortmans P; Weber WP; Thürlimann B;
Ann Oncol; 2023 Nov; 34(11):970-986. PubMed ID: 37683978
[TBL] [Abstract][Full Text] [Related]
4. Estimating the benefits of therapy for early-stage breast cancer: the St. Gallen International Consensus Guidelines for the primary therapy of early breast cancer 2019.
Burstein HJ; Curigliano G; Loibl S; Dubsky P; Gnant M; Poortmans P; Colleoni M; Denkert C; Piccart-Gebhart M; Regan M; Senn HJ; Winer EP; Thurlimann B;
Ann Oncol; 2019 Oct; 30(10):1541-1557. PubMed ID: 31373601
[TBL] [Abstract][Full Text] [Related]
5. St. Gallen/Vienna 2017: A Brief Summary of the Consensus Discussion about Escalation and De-Escalation of Primary Breast Cancer Treatment.
Gnant M; Harbeck N; Thomssen C
Breast Care (Basel); 2017 May; 12(2):102-107. PubMed ID: 28559767
[TBL] [Abstract][Full Text] [Related]
6. The St. Gallen International Expert Consensus Conference on the Primary Therapy of Early Breast Cancer 2017: Egyptian view.
Khaled H; Gamal H; Lotayef M; Knauer M; Thürliman B
Breast Cancer Res Treat; 2018 Dec; 172(3):545-550. PubMed ID: 30218194
[TBL] [Abstract][Full Text] [Related]
7. Highlights from the 15th St Gallen International Breast Cancer Conference 15-18 March, 2017, Vienna: tailored treatments for patients with early breast cancer.
Morigi C
Ecancermedicalscience; 2017; 11():732. PubMed ID: 28491135
[TBL] [Abstract][Full Text] [Related]
8. Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013.
Goldhirsch A; Winer EP; Coates AS; Gelber RD; Piccart-Gebhart M; Thürlimann B; Senn HJ;
Ann Oncol; 2013 Sep; 24(9):2206-23. PubMed ID: 23917950
[TBL] [Abstract][Full Text] [Related]
9. Primary Therapy of Patients with Early Breast Cancer: Evidence, Controversies, Consensus: Opinions of German Specialists to the 14th St. Gallen International Breast Cancer Conference 2015 (Vienna 2015).
Untch M; Harbeck N; Huober J; von Minckwitz G; Gerber B; Kreipe HH; Liedtke C; Marschner N; Möbus V; Scheithauer H; Schneeweiss A; Thomssen C; Jackisch C; Beckmann MW; Blohmer JU; Costa SD; Decker T; Diel I; Fasching PA; Fehm T; Janni W; Lück HJ; Maass N; Scharl A; Loibl S
Geburtshilfe Frauenheilkd; 2015 Jun; 75(6):556-565. PubMed ID: 26166836
[TBL] [Abstract][Full Text] [Related]
10. Overview of resistance to systemic therapy in patients with breast cancer.
Gonzalez-Angulo AM; Morales-Vasquez F; Hortobagyi GN
Adv Exp Med Biol; 2007; 608():1-22. PubMed ID: 17993229
[TBL] [Abstract][Full Text] [Related]
11. National Institutes of Health Consensus Development Conference statement: adjuvant therapy for breast cancer, November 1-3, 2000.
National Institutes of Health Consensus Development Panel
J Natl Cancer Inst Monogr; 2001; (30):5-15. PubMed ID: 11773285
[TBL] [Abstract][Full Text] [Related]
12. Conservative surgery after neoadjuvant chemotherapy in patients with operable breast cancer.
Franceschini G; Di Leone A; Natale M; Sanchez MA; Masett R
Ann Ital Chir; 2018; 89():290. PubMed ID: 30352955
[TBL] [Abstract][Full Text] [Related]
13. Initial Treatment of Patients with Primary Breast Cancer: Evidence, Controversies, Consensus: Spectrum of Opinion of German Specialists at the 15th International St. Gallen Breast Cancer Conference (Vienna 2017).
Untch M; Huober J; Jackisch C; Schneeweiss A; Brucker SY; Dall P; Denkert C; Fasching PA; Fehm T; Gerber B; Janni W; Kühn T; Lüftner D; Möbus V; Müller V; Rody A; Sinn P; Thill M; Thomssen C; Harbeck N; Liedtke C
Geburtshilfe Frauenheilkd; 2017 Jun; 77(6):633-644. PubMed ID: 28769126
[TBL] [Abstract][Full Text] [Related]
14. Highlights of the 16th St Gallen International Breast Cancer Conference, Vienna, Austria, 20-23 March 2019: personalised treatments for patients with early breast cancer.
Morigi C
Ecancermedicalscience; 2019; 13():924. PubMed ID: 31281421
[TBL] [Abstract][Full Text] [Related]
15. Customizing local and systemic therapies for women with early breast cancer: the St. Gallen International Consensus Guidelines for treatment of early breast cancer 2021.
Burstein HJ; Curigliano G; Thürlimann B; Weber WP; Poortmans P; Regan MM; Senn HJ; Winer EP; Gnant M;
Ann Oncol; 2021 Oct; 32(10):1216-1235. PubMed ID: 34242744
[TBL] [Abstract][Full Text] [Related]
16. St. Gallen/Vienna 2015: A Brief Summary of the Consensus Discussion.
Gnant M; Thomssen C; Harbeck N
Breast Care (Basel); 2015 Apr; 10(2):124-30. PubMed ID: 26195941
[TBL] [Abstract][Full Text] [Related]
17. Adjuvant therapy for breast cancer.
NIH Consens Statement; 2000 Nov 1-3; 17(4):1-35. PubMed ID: 11512506
[TBL] [Abstract][Full Text] [Related]
18. National Institutes of Health Consensus Development Conference Statement: adjuvant therapy for breast cancer, November 1-3, 2000.
Eifel P; Axelson JA; Costa J; Crowley J; Curran WJ; Deshler A; Fulton S; Hendricks CB; Kemeny M; Kornblith AB; Louis TA; Markman M; Mayer R; Roter D
J Natl Cancer Inst; 2001 Jul; 93(13):979-89. PubMed ID: 11438563
[TBL] [Abstract][Full Text] [Related]
19. Treatment of breast cancer in countries with limited resources.
Carlson RW; Anderson BO; Chopra R; Eniu AE; Jakesz R; Love RR; Masetti R; Schwartsmann G;
Breast J; 2003; 9 Suppl 2():S67-74. PubMed ID: 12713499
[TBL] [Abstract][Full Text] [Related]
20. Strategies for subtypes--dealing with the diversity of breast cancer: highlights of the St. Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011.
Goldhirsch A; Wood WC; Coates AS; Gelber RD; Thürlimann B; Senn HJ;
Ann Oncol; 2011 Aug; 22(8):1736-47. PubMed ID: 21709140
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
